Document is current
Any future updates will be listed below
-
Authors
Burr, Alexandra https://orcid.org/0000-0002-7954-3619
Parekkadan, Biju
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01GM127353, R01EB012521)
National Institute of General Medical Sciences (T32GM008339)
- License Information
-
More Information
Article History
Received: 25 February 2019
Accepted: 23 July 2019
First Online: 13 August 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: B.P. is a founder and equity holder of Sentien Biotechnologies, Inc whom have licensed patents pertaining to MSC therapeutics. The authors declare no other competing interests.
